Just Released
|
|||
Visualizing Health Policy: US Public's Perspective on Prescription
Drug Costs
This
Visualizing Health Policy infographic examines public
opinion on prescription drug costs in the United States (US). Over the past
20 years, US drug spending has increased by 330% compared to a 208% increase
in total US health expenditures. A large majority (78%) of the public see
drug company profits as the top contributor to higher health care spending.
Lowering drug costs is the public’s top health policy priority for the US
Congress. While most adults (59%) say prescription drugs have made
their lives better, many (79%) also say the cost is unreasonable. Three in 10
report they have not taken medications as prescribed in the past year because
of the cost. Across political affiliation, the public supports many actions
to lower drug costs. Requiring drug companies to include list prices in ads,
making it easier for generics to come to market, and allowing the government
to negotiate with drug companies were among the most popular strategies.
Visualizing
Health Policy is an infographic series produced in
partnership with the Journal of the American Medical Association (JAMA).
The full-size infographic is freely available on
JAMA’s website and is published in the print edition of the journal.
Filling
the need for trusted information on national health issues, the Kaiser Family Foundation is
a nonprofit organization based in San Francisco, California.
|
|||
|
|||
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Thursday, April 23, 2020
New Infographic: US Public’s Perspective on Prescription Drug Costs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment